Ticagrelor, February 2016
Page last updated: 8 July 2016
Drug utilisation sub-committee (DUSC)
February 2016
Abstract
Purpose
To review the predicted versus actual use of ticagrelor for acute coronary syndrome, as requested by DUSC at its October 2015 meeting.
Date of listing on the Pharmaceutical Benefits Scheme (PBS)
Ticagrelor was first listed on the PBS on 1 August 2012 for acute coronary syndrome.
Data Source / methodology
Prescription data were extracted from the Department of Human Services (DHS) prescription database for the period August 2012 to July 2015, inclusive. The analyses completed include the number of prescriptions and patients over time and the length of time patients are receiving treatment with ticagrelor.
Key Findings
- Since listing, 32,268 patients have been treated with ticagrelor. In 2014:
- 19,770 patients were dispensed at least one prescription of ticagrelor;
- 12,684 of these patients were starting treatment with ticagrelor for the first time.
- The length of treatment analysis suggests that although some patients remain on treatment for more than two years, the majority have stopped taking ticagrelor one year after initiation.
Full Report
